Evusheld is a combination of two monoclonal antibodies that are used for pre-exposure prophylaxis against COVID in patients who are moderately to severely immunocompromised. It has been shown to reduce the risk of infection in this population. It is given as two intramuscular injections in the gluteus (buttock). You will be observed for an hour afterward to monitor for reaction.

Evusheld is being administered under an FDA Emergency Use Authorization and is NOT FDA approved. It is not a substitute for vaccination and will not be given in place of vaccination. There are possible adverse effects associated with it (albeit low) including: headache, fatigue, and cough. There was also an increase in adverse cardiac events (going from about 0.2% to 0.6%). This class of medication has been known to cause anaphylaxis too.

In order to sign-up for administration, please fill out this form. We will contact you to schedule an appointment for evaluation and administration of the drug.

This if the fact sheet for Evusheld. Please review it prior to coming for your appointment.